Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Oral GLP-1RA TERN-601 for Adults With Obesity/Overweight: Placebo-Controlled, Multiple-Ascending-Dose, Phase 1 and 2 Studies.
Journal: Obesity (Silver Spring, Md.)
Published: April 13, 2026
Semi-Mechanistic PK/PD Modeling and Simulation of Irreversible BTK Inhibition to Support Dose Selection of Tirabrutinib in Subjects with RA.
Journal: Clinical pharmacology and therapeutics
Published: June 09, 2021
Filgotinib, a JAK1 Inhibitor, Has No Effect on QT Interval in Healthy Subjects.
Journal: Clinical pharmacology in drug development
Published: November 09, 2018
Pharmacokinetics and Disposition of Momelotinib Revealed a Disproportionate Human Metabolite-Resolution for Clinical Development.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: October 12, 2017
Pharmacokinetics and Safety of Momelotinib in Subjects With Hepatic or Renal Impairment.
Journal: Journal of clinical pharmacology
Published: September 13, 2017
Showing 1-5 of 5
Last Updated: 09/26/2026